Application 212782

Type
NDA
Sponsor
SHILPA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BORTEZOMIBBORTEZOMIBSOLUTION;INTRAVENOUS, SUBCUTANEOUS3.5MG/1.4ML (2.5MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83659ORIG 2025-10-06
79496ORIG 2024-08-29
79487ORIG 2024-08-27